key: cord-0768680-tn6149rk
authors: Currie, Dustin W.; Shah, Melisa M.; Salvatore, Phillip P.; Ford, Laura; Whaley, Melissa J.; Meece, Jennifer; Ivacic, Lynn; Thornburg, Natalie J.; Tamin, Azaibi; Harcourt, Jennifer L.; Folster, Jennifer; Medrzycki, Magdalena; Jain, Shilpi; Wong, Phili; Goffard, Kimberly; Gieryn, Douglas; Kahrs, Juliana; Langolf, Kimberly; Zochert, Tara; Hsu, Christopher H.; Kirking, Hannah L.; Tate, Jacqueline E.
title: Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures
date: 2022-03-03
journal: Emerg Infect Dis
DOI: 10.3201/eid2803.211747
sha: 6caee8ef724781c05a5b53fd0ead3c42e6f6b2cc
doc_id: 768680
cord_uid: tn6149rk

We assessed the relationship between antigen and reverse transcription PCR (RT-PCR) test positivity and successful virus isolation. We found that antigen test results were more predictive of virus recovery than RT-PCR results. However, virus was isolated from some antigen-negative and RT-PCR‒positive paired specimens, providing support for the Centers for Disease Control and Prevention antigen testing algorithm.

We assessed the relationship between antigen and reverse transcription PCR (RT-PCR) test positivity and successful virus isolation.We found that antigen test results were more predictive of virus recovery than RT-PCR results. However, virus was isolated from some antigen-negative and RT-PCR-positive paired specimens, providing support for the Centers for Disease Control and Prevention antigen testing algorithm.

We attempted viral culture at a CDC laboratory for all participants testing positive by RT-PCR or antigen test by using Vero-CCL81 cells, which were inoculated with clinical specimens, and observed daily for 7 days (8) . All cultures that had a visible cytopathic effect were used for RNA extraction and SARS-CoV-2 RT-PCR confirmation. Any specimen that showed a cytopathic effect, was positive by RT-PCR, and had a C t >2 lower than that for the original clinical specimen was considered culture positive.

We collected symptoms at time of specimen collection, symptom onset date, and exposure history by using paper questionnaires and entered data into RED-Cap database version 11.0.3 (https://www.vumc.org/ dbmi/redcap). Participants reporting >1 of 15 symptoms at the time of specimen collection were considered symptomatic. Possible symptoms were fever, rigors, nasal congestion, sore throat, shortness of breath, headache, diarrhea, loss of taste, loss of smell, chills, muscle aches, fatigue, cough, nausea, and abdominal pain.

We define known exposure as being within 6 feet of a person who tested positive for SARS-CoV-2 within the last 14 days for >15 minutes over a 24-hour period. We analyzed data by using SAS version 9.4 (https://www.sas.com). We made comparisons by using Kruskal-Wallis tests for continuous variables or χ 2 tests for categorical variables; statistical significance was defined as α<0.05. This analysis was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.

During November 16-December 15, 2020, we collected 2,112 specimen pairs that had valid results for PCR and antigen tests; most (56.3%) participants were symptomatic (age range 5-95 years, median 42 years). Of 2,112 specimen pairs, 334 (15.8%) were positive by RT-PCR, 269 (12. All participants who had culture-positive specimens and false-negative antigen tests were symptomatic (7/9; 77.8%) or had a known exposure in the past 14 days (5/9; 55.6%). Among culture-positive symptomatic participants, those who had false-negative antigen and concordant positive antigen/RT-PCR results were tested a similar number of days after symptom onset (median 2 days vs. 3 days) ( Table 2 ). The 2 persons who had recoverable virus and false-negative antigen test results and who were asymptomatic at the time of testing had known exposures the day before testing. For those who had recoverable virus, nucleocapsid gene C t values were significantly lower in those with concordant positive results (median 19.1, interquartile range 17.1-21.3) than those who had false-negative antigen test results (median 26.6, interquartile range 25.6-31.0) (p<0.0001) (Table 2; Figure) .

Consistent with previous studies assessing the relationship between antigen tests, RT-PCR, and ability to culture virus (9-11), we found that SARS-CoV-2 was more likely to be recovered among specimen pairs for which antigen test and RT-PCR results were positive than among pairs in which antigen test results were negative and RT-PCR results were positive. Although some studies have shown similar PPV for viral culture when comparing RT-PCR and antigen tests (12), we found higher PPV for the antigen test than for RT-PCR (13) , suggesting that antigen test positivity might be a better marker of infectiousness than a positive RT-PCR result. However, a small but nontrivial proportion of samples that had negative antigen and positive RT-PCR results had recoverable virus, suggesting that antigen tests are misclassifying some infectious persons as SARS-CoV-2 negative. This finding, consistent with those of similar studies (6) (7) (8) (9) (10) (11) , suggests that lower sensitivity of antigen tests when compared with RT-PCR cannot be attributed exclusively to lingering positive RT-PCR results for persons who are no longer infectious.

Symptoms on the day of testing for most infectious persons who had false-negative antigen test results suggests that CDC's current antigen testing guidance, which recommends confirmatory RT-PCR testing after negative antigen test results for symptomatic persons in community settings (14) participants who had false-negative antigen test results and recoverable virus had exposures within the previous 48 hours. Therefore, all participants who had false-negative antigen test results were unlikely to infect others if following CDC guidance because they would have been advised to quarantine because of exposure (asymptomatic close contacts) or while awaiting confirmatory RT-PCR results (symptomatic persons). One limitation of this study was that although recoverable virus is indicative of infectiousness, lack of ability to isolate virus does not necessarily imply lack of infectiousness (15) . Symptom status was only measured at the time of testing. Because we did not attempt virus isolation on antigen-negative and RT-PCR-negative specimens, PPV was the only reported measure of agreement between antigen test, RT-PCR, and recoverable virus in culture. Because RT-PCR testing was not performed with calibrators, we are not able to report values in copies/milliliter. Finally, this investigation assessed only the BinaxNOW antigen testing platform. This study suggests that antigen test positivity is more predictive of infectiousness than RT-PCR test positivity. However, false-negative antigen test results can be obtained for infectious persons, especially among those with symptoms, supporting CDC recommendations to follow negative antigen testing among symptomatic persons with RT-PCR confirmatory testing within 48 hours (14) .

of the CDC COVID-19 Response Epidemiology Field Studies Team: Fatima Abdirizak (CDC)

Performance of repeat BinaxNOW SARS-CoV-2 antigen testing in a community setting

Evaluation of Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites-Pima County

Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high throughput drive-through community testing site in Massachusetts

Field performance and public health response using the BinaxNOW TM rapid SARS-CoV-2 antigen detection assay during community-based testing

Viral cultures for COVID-19 infectious potential assessment: a systematic review

Determining the infectious potential of individuals with positive reverse transcription polymerase chain reaction severe acute respiratory syndrome 2 tests

Evaluation of the Roche antigen rapid test and a cell culture-based assay compared to rRT-PCR for the detection of SARS-CoV-2: a contribution to the discussion about SARS-CoV-2 diagnostic tests and contagiousness

Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States

Performance of a point-of-care test for the rapid detection of SARS-CoV-2 antigen

The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro

CDC Infection Prevention and Control Team and the CDC COVID-19 Surge Laboratory Group. Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak

Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing

Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture

Using antigen tests for SARS-CoV-2 in community settings

Repeat COVID-19 molecular testing: correlation of SARS-CoV-2 culture with molecular assays and cycle thresholds

We thank the participants in Wisconsin for contributing to this investigation, and the US Department of Health and Human Services community-based testing program for making this investigation possible.

Dr. Currie is an Epidemic Intelligence Service Officer in the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA. His research interests include general population HIV surveillance, COVID-19 outbreak investigation, testing strategies for SARS-CoV-2 infection, and the relationship between behavioral science and communicable diseases.